unlearn.ai
TwinRCTs by unlearn
Unlearn.ai's TwinRCTs: Revolutionizing Clinical Trials with Patient Digital Twins
Overview
TwinRCTs by unlearn.ai introduces a groundbreaking approach to clinical research using patient-specific digital twins powered by artificial intelligence. This innovative technology allows for more informed decision-making, faster trial enrollment, and optimized treatment observation, all without increasing participant numbers. By generating accurate digital replicas based on extensive historical clinical data, TwinRCTs enables precise predictions of clinical outcomes at any future point, facilitating early go/no-go decisions. It supports designing smaller, more efficient randomized controlled trials aligned with regulatory standards like EMA and FDA guidance. The platform accelerates clinical development timelines, reduces trial costs, and enhances data insights across various disease areas including Alzheimer’s, ALS, and metabolic diseases. Collaborations with leading biopharma companies demonstrate its real-world application, with notable results such as a 33% reduction in control arm size and four months saved in enrollment time. TwinRCTs is transforming how clinical trials are designed, conducted, and analyzed, making therapies accessible faster and more efficiently than ever before.
Key features & benefits
AI-generated patient digital twins for precise clinical outcome predictions
Accelerated trial timelines and resource savings
Smaller, more efficient randomized controlled trials
Enhanced decision-making with real-time outcome forecasts
Supports trial design optimization and regulatory compliance
Applicable across neuroscience, immunology, metabolic diseases
Use cases & applications
Accelerating drug development in Alzheimer’s and neurological disorders
Optimizing clinical trial design and participant selection
Reducing trial costs and duration
Supporting interim analyses and go/no-go decisions
Enhancing trial accuracy and success rates
Who it's for
Side hustle idea
A way you could turn this tool into income
Leveraging digital twin technology offers entrepreneurs and startups a unique opportunity to develop specialized AI platforms for clinical trial optimization. By creating tailored solutions for biotech firms and research institutions, new businesses can tap into the growing demand for efficient, cost-effective drug development tools. Offering consulting, data analysis, or custom digital twin services could open lucrative pathways in the expanding field of AI-driven healthcare innovation.
Reviews
0.0
from 0 reviews
No reviews yet — be the first to share your experience.